NEW YORK (Reuters Health) – Adding angioplasty to medical therapy does not improve the outcomes of patients with renal-artery stenosis and carries substantial risks, according to a report…
NEW YORK (Reuters Health) – Keeping hypoxic patients with acute respiratory distress syndrome (ARDS) in the prone position does not reduce mortality, although it might provide a slight…
NEW YORK (Reuters Health) – Long-term ambrisentan therapy safely improves exercise capacity in patients with pulmonary arterial hypertension (PAH), according to results of an extension protocol that followed…
NEW YORK (Reuters Health) – In kidney transplant recipients, bringing hemoglobin levels above 125 g/L with erythropoietin may increase mortality, according to a report in the November 6th…
NEW YORK (Reuters Health) – Exercise-induced ST-segment elevation in patients who never had a myocardial infarction (MI) is a highly specific marker of coronary artery disease and a…
NEW YORK (Reuters Health) – Blood transfusion is safe and may be beneficial in patients with acute decompensated heart failure, say researchers from Israel in the October American…
NEW YORK (Reuters Health) – Giving abciximab to high-risk patients with ST-elevation myocardial infarction (STEMI) before transferring them for percutaneous coronary intervention (PCI) reduces 1-year mortality without increasing…
NEW YORK (Reuters Health) – Individuals with minimal or no coronary calcification face a low risk of cardiovascular events, according to results from the Multi-Ethnic Study of Atherosclerosis…
NEW YORK (Reuters Health) – Using hypertonic saline with nebulized epinephrine instead of normal saline does not improve the clinical outcomes of infants in the ER with mild…
NEW YORK (Reuters Health) – No matter whether they receive biological or mechanical prosthetic aortic valves, patients have generally similar survival and complication rates — until 10 years…